Latest Releases

If you would like to be alerted when a press release is added to this site, please register with the Alert Service.

Select a Month:
Select a Year:
Search for:
Run your search


Date Title
20/12/2005 Vernalis Successfully Completes Frovatriptan Phase III Open Label Safety Study in Prevention of Menstrual Migraine
19/12/2005 Vernalis Achieves Milestone in Oncology Collaboration
14/12/2005 Vernalis completes the acquisition of Cita NeuroPharmaceuticals Inc
13/12/2005 Results of EGM and Placing and Open Offer
18/11/2005 Proposed acquisition of Cita Neuropharmaceuticals Inc
Proposed Vendor Placing
Proposed Placing and Open Offer
04/11/2005 Collaboration with Britannia to Develop New Formulations of Apomorphine for the Treatment of Parkinson’s Disease
04/11/2005 Vernalis Acquires Rights to Apokyn®, a Marketed Drug for Advanced Parkinson’s Disease, from Mylan
22/09/2005 Interim Results for the six months ended 30 June 2005
22/09/2005 Vernalis Reports Appointment of Piper Jaffray as Joint Broker
06/09/2005 Vernalis Reports Completion of Recruitment on Frovatriptan Phase III Efficacy Study
Page 1  2  3    >>